Please login to the form below

Not currently logged in
Email:
Password:

sitagliptin

This page shows the latest sitagliptin news and features for those working in and with pharma, biotech and healthcare.

Givlaari, Rybelsus lead crowded CHMP recommendations

Givlaari, Rybelsus lead crowded CHMP recommendations

In Novo’s Pioneer programme of the drug, people treated with Rybelsus achieved greater blood glucose reductions compared to Merck &Co’s DPP-4 inhibitor Januvia (sitagliptin), Boehringer Ingelheim and Eli

Latest news

More from news
Approximately 8 fully matching, plus 88 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics